Category Archives: News
Translating the microbiome – what’s the target?
Posted in News
Comments Off on Translating the microbiome – what’s the target?
CME Exam 1: Recurrent Lower Abdominal Pain, Altered Bowel Habits, and Malaise: Conservative or Surgical Approach to a Common Disorder
Posted in News
Comments Off on CME Exam 1: Recurrent Lower Abdominal Pain, Altered Bowel Habits, and Malaise: Conservative or Surgical Approach to a Common Disorder
Improving the Experiences of Sexual and Gender Minority-Identifying Trainees in Gastroenterology and Hepatology
I don’t believe in gay marriageThe words reverberated off the endoscopy walls and echoed through us. It was unprompted and felt like a sucker punch to the gut. We believed this to be a safe space where we could learn and be ourselves. But the statement… Continue reading
Posted in News
Comments Off on Improving the Experiences of Sexual and Gender Minority-Identifying Trainees in Gastroenterology and Hepatology
Elsewhere in The AGA Journals (Preview Section)
Posted in News
Comments Off on Elsewhere in The AGA Journals (Preview Section)
CME Exam 2: Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis
Posted in News
Comments Off on CME Exam 2: Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis
AGA Clinical Practice Update on Gastric Peroral Endoscopic Myotomy for Gastroparesis: Commentary
The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update (CPU) is to review the available evidence and provide expert advice regarding cognitive, procedural, and post-procedural aspects of performing gastric… Continue reading
Posted in News
Comments Off on AGA Clinical Practice Update on Gastric Peroral Endoscopic Myotomy for Gastroparesis: Commentary
EFFECTS OF FGF19 ANALOG ALDAFERMIN IN PATIENTS WITH BILE ACID DIARRHEA: A RANDOMIZED, PLACEBO-CONTROL TRIAL
Posted in News
Comments Off on EFFECTS OF FGF19 ANALOG ALDAFERMIN IN PATIENTS WITH BILE ACID DIARRHEA: A RANDOMIZED, PLACEBO-CONTROL TRIAL